TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.

TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines.
复制标题

DOI:
10.1007/s00262-012-1217-5
复制
发表时间:
2012-10
影响因子:
5.8
通讯作者:
Slansky, Jill E.
Slansky, Jill E.
中科院分区:
医学3区
文献类型:
--
作者:
Jordan, Kimberly R.;Buhrman, Jonathan D.;Sprague, Jonathan;Moore, Brandon L.;Gao, Dexiang;Kappler, John W.;Slansky, Jill E.

文献摘要

参考文献

被引文献

相似文献

A major goal of immunotherapy for cancer is the activation of T cell responses against tumor-associated antigens (TAAs). One important strategy for improving antitumor immunity is vaccination with peptide variants of TAAs. Understanding the mechanisms underlying the expansion of T cells that respond to the native tumor antigen is an important step in developing effective peptide-variant vaccines. Using an immunogenic mouse colon cancer model, we compare the binding properties and the TCR genes expressed by T cells elicited by peptide variants that elicit variable antitumor immunity directly ex vivo. The steady-state affinity of the natural tumor antigen for the T cells responding to effective peptide vaccines was higher relative to ineffective peptides, consistent with their improved function. Ex vivo analysis showed that T cells responding to the effective peptides expressed a CDR3β motif, which was also shared by T cells responding to the natural antigen and not those responding to the less effective peptide vaccines. Importantly, these data demonstrate that peptide vaccines can expand T cells that naturally respond to tumor antigens, resulting in more effective antitumor immunity. Future immunotherapies may require similar stringent analysis of the responding T cells to select optimal peptides as vaccine candidates. The online version of this article (doi:10.1007/s00262-012-1217-5) contains supplementary material, which is available to authorized users.
DOI: 10.1126/science.1129003
发表时间: 2006-10-06
期刊: SCIENCE
影响因子: 56.9
作者:
Morgan, Richard A.;Dudley, Mark E.;Rosenberg, Steven A.
通讯作者: Rosenberg, Steven A.
DOI: 10.1016/s1074-7613(01)00096-6
发表时间: 2001-02-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Fahmy, TM;Bieler, JG;Schneck, JP
通讯作者: Schneck, JP
DOI: 10.1172/jci26936
发表时间: 2006-09-01
影响因子: 15.9
作者:
McMahan, Rachel H.;McWilliams, Jennifer A.;Slansky, Jill E.
通讯作者: Slansky, Jill E.
DOI: 10.4049/jimmunol.180.3.1526
发表时间: 2008-02-01
影响因子: 4.4
作者:
Hou, Yafei;Kavanagh, Brian;Fong, Lawrence
通讯作者: Fong, Lawrence
DOI: 10.1097/01.cji.0000161398.34701.26
发表时间: 2005-05-01
影响因子: 3.9
作者:
Le Gal, FA;Ayyoub, M;Valmori, D
通讯作者: Valmori, D